Neith Corporation

Research Neith Corporation (6236.TWO) on Bullrun: market cap TWD 676.88M, P/E 1625.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 676.88M; P/E is 1625.0.

Peer valuation comparison

Latest P/E is 1625x versus a Healthcare sector median of 21.8x (7355.8% above).

Latest P/E is 1625x versus a Taiwan median of 18.67x (8604.6% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 676.88M1625.0n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About Neith Corporation

Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company provides nutritional products, including L-One, a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; and other nutritional products under the King One name. It also offers genetic testing services.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Neith Corporation's market cap?

Neith Corporation's market capitalization is TWD 676.88M.

What is Neith Corporation's P/E ratio?

Neith Corporation's price-to-earnings (P/E) ratio is 1625.0.

What does Neith Corporation do?

Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company provides nutritional products, including L-One, a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; and other nutritional products under the King One name. It also offers genetic testing services. In addition, the company offers energy and dual-purpose mattresses, energy masks, energy silicon gel necklaces, energy waistbands, energy heating stones, massage rods, and water purifiers, as well as Ganbanyoku, an energy stone spa bed.